FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Editas Medicine, Inc. EDIT

Biological Products, (No Diagnostic Substances) · SIC 2836

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-09 · Retrieved: 2026-11-13

Compared with the same period of the prior year, ending 2025-09-30.

Revenue10.37

USD million

Change year over year: +2.82 · +37.4%

Net income-23.39

USD million

Change year over year: +1.72

Operating cash flow-21.19

USD million

Change year over year: +9.65

Total liabilities134.89

USD million

Change year over year: -53.41

Total assets219.41

USD million

Change year over year: +17.66

Liabilities / assets: 61.5% · Change: -31.9 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-09 · Retrieved: 2026-11-13

Compared with the same period of the prior year, ending 2024-12-31.

Revenue40.52

USD million

Change year over year: +8.21 · +25.4%

Net income-160.06

USD million

Change year over year: +77.03

Operating cash flow-165.24

USD million

Change year over year: +45.04

Total liabilities159.25

USD million

Change year over year: -48.07

Total assets186.53

USD million

Change year over year: -155.06

Liabilities / assets: 85.4% · Change: +24.7 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
ACOG ↗	2025-12-31	10.22	-202.2%	-199.4%
FDMT ↗	2025-12-31	85.21	-164.4%	-128.0%
TECH ↗	2026-06-30	1,215.04	15.0%	24.0%
ATRA ↗	2025-12-31	120.77	27.1%	-42.2%
ARTV ↗	2025-12-31	0.00	—	—
IMA ↗	2025-12-31	0.80	-5,668.6%	-5,980.5%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

CPHC ↗

Canterbury Park Holding Corp

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

ABSI ↗

Absci Corp

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

YETI ↗

YETI Holdings, Inc.

Filed: 2026-11-12
Period ending: 2026-10-03

Latest standalone quarter

BSEM ↗

BioStem Technologies, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

PBLS ↗

Parabilis Medicines, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

ACOG ↗

Alpha Cognition Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

SNRG ↗

SusGlobal Energy Corp.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

FDMT ↗

4D Molecular Therapeutics, Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

ONDS ↗

Ondas Inc.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

MNPR ↗

Monopar Therapeutics

Filed: 2026-11-12
Period ending: 2026-09-30

Latest annual report

RMR ↗

RMR GROUP INC.

Filed: 2026-11-12
Period ending: 2026-09-30

Latest standalone quarter

ITHUF ↗

iANTHUS CAPITAL HOLDINGS, INC.

Filed: 2026-11-12
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →